HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yeo Jue Byun Selected Research

1-phenyl-3,3-dimethyltriazene (PDT)

3/2010Intravitreal anti-VEGF versus photodynamic therapy with verteporfin for treatment of myopic choroidal neovascularization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yeo Jue Byun Research Topics

Disease

2Choroidal Neovascularization
05/2012 - 03/2010
1Atrophy
05/2012
1Macular Degeneration (Age-Related Maculopathy)
11/2010
1Macular Edema
07/2010
1Retinal Vein Occlusion
07/2010

Drug/Important Bio-Agent (IBA)

3Bevacizumab (Avastin)FDA Link
11/2010 - 03/2010
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2012 - 03/2010
2Fluorescein (Funduscein)FDA LinkGeneric
05/2012 - 11/2010
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
05/2012
1Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
07/2010
1Ranibizumab (Lucentis)FDA Link
03/2010
1Endothelial Growth FactorsIBA
03/2010
11-phenyl-3,3-dimethyltriazene (PDT)IBA
03/2010
1Verteporfin (Visudyne)FDA Link
03/2010

Therapy/Procedure

2Therapeutics
11/2010 - 07/2010
2Aftercare (After-Treatment)
07/2010 - 03/2010
1Injections
07/2010
1Photochemotherapy (Photodynamic Therapy)
03/2010